RH

Rohan Hockings

PYC Therapeutics Limited | Executive Director, Chief Executive Officer
Dr Hockings spent four years with McKinsey & Company and a further two years in the Private Equity industry before joining PYC Therapeutics. He brings an affinity for conceptual thinking to PYC Therapeutics along with an understanding of the company's technology and its commercialization path. Dr Hockings is a founding principal of a private equity fund active in the acquisition of health care assets within Australia. His previous roles include strategy and operational advisory positions with a global management consulting firm, equity capital markets experience as a solicitor with a national law firm and several appointments as a medical practitioner. Dr Hockings has a special interest in both venture capital and private equity within the healthcare industry. He has worked across both disciplines following an internship at Sir Charles Gairdner Hospital and admission to practice in the Supreme Court of Victoria respectively.

Company and Roles

Company
Title
Tenure
Since
PYC
PYC Therapeutics Limited
  • Executive Director
  • Chief Executive Officer
8yrs, 3mthAug 2016

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PYC
PYC Therapeutics Limited
03/01/24000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PYC
PYC Therapeutics Limited
03/01/24
Transfer
18,181,818$0.100$1,818,181Off-market transfer
PYC
PYC Therapeutics Limited
10/07/23
Transfer
10,000,000$0.062$620,000Off-market transfer
PYC
PYC Therapeutics Limited
10/07/23
Issued
18,181,818$0.055$999,999Placement
PYC
PYC Therapeutics Limited
10/06/21
Buy
10,000,000$0.039$390,000Exercise of options
PYC
PYC Therapeutics Limited
10/06/21
Exercise
10,000,000$0.039$390,000Exercise of options